bioAffinity Technologies press release (BIAF): Q3 GAAP EPS of -$5.89. Revenue of $1.1M (-21.4% Y/Y). Cash and cash equivalents of approximately $2.6M as of Sept
CryptoAlerta — análise de criptomoedas e mercado em tempo real